• Most Popular
  • Most Shared

Lilly seeks approval for Cymbalta in fibromyalgia

Tue Aug 21, 2007 8:25am EDT

Stocks

   

BOSTON, Aug 21 (Reuters) - Eli Lilly and Co. (LLY.N) said on Tuesday it has filed for U.S. approval to sell its antidepressant Cymbalta as a treatment for the pain condition fibromyalgia.

Regulatory News

The company said data shows that patients with and without depression who took Cymbalta showed greater reduction in pain than those who took a placebo.

Fibromyalgia is estimated to affect 2 percent to 4 percent of the U.S. population. It is characterized by widespread pain and fatigue, sometimes to a disabling degree.

Cymbalta is approved in the United States for the treatment of major depression, nerve pain associated with diabetes, and generalized anxiety.

Regulatory News


More from Reuters

Photo

U.S. retailers open past midnight in holiday push

NEW YORK (Reuters) - In the nights before Christmas, some U.S. retailers are opening their doors round the clock to wring out every last possible holiday sale. | Video

» More Top News
A glass of water taken from a residential well after the start of natural gas drilling in Dimock, Pennsylvania, March 7, 2009. Dimock is one of hundreds of sites in Pennsylvania where energy companies are now racing to tap the massive Marcellus Shale natural gas formation. REUTERS/Tim Shaffer

Not in my watershed: NYC

The biggest U.S. city wants the state to ban one of the most promising sources of U.S. energy -- and also one of the most contentious.  Full Article 

Green Business
Cannabis sativa plant is seen in Buenos Aires, August 21, 2009. REUTERS/Enrique Marcarian
Bernd Debusmann:

Obama, drugs, common sense

American attitudes towards drug prohibition – and above all, punitive laws on marijuana – are changing too fast for policymakers and legislators to ignore.  Commentary 

U.S.